Search Results 1251-1260 of 18258 for anaphylaxis

  1. Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab - Mayo Clinic

    Documented history of anaphylaxis. Onset of malignancy of any organ system within the past 5 year (except for basal cell carcinoma or actinic keratoses or ...

  2. Burosumab-twza (subcutaneous route) - Side effects & uses - Mayo Clinic

    Burosumab-twza injection is used to treat X-linked hypophosphatemia (low phosphate levels in the blood). This medicine is also used to treat FGF23-related ...

  3. Eosinophilia Causes - Mayo Clinic

    Eosinophilia (e-o-sin-o-FILL-e-uh) is the presence of too many eosinophils in the body. An eosinophil is part of a group of cells called white blood cells.

  4. A Study to Evaluate the Safety and Effectiveness of JBH492 in Patients with Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma - Mayo Clinic

    History of anaphylactic or other severe hypersensitivity/infusion reactions to ADCs, monoclonal antibodies (mAbs) and/or their excipients such that the ...

  5. Early Fluconazole Treatment for Coccidiodomycosis Pneumonia - Mayo Clinic

    Pregnant or lactating females. History of azole intolerance or allergy or severe allergic reaction (e.g., anaphylaxis) to Spherusol® or any component of ...

  6. RESET-MG: A Study To Evaluate The Safety And Efficacy Of CABA-201 In Participants With Generalized Myasthenia Gravis - Mayo Clinic

    * History of anaphylactic or severe systemic reaction to fludarabine, cyclophosphamide or any of their metabolites * Active infection requiring medical ...

  7. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

    History of Grade 4 infusion-related, anaphylactic or allergic reaction to any previous Fc-based protein therapy. Participating Mayo Clinic locations. Study ...

  8. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

    History of anaphylaxis (excluding infusion related reactions) in association with previous antiCD20 administration (for subjects eligible to enroll to an ...

  9. Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery and Sub-Study of Clinical Protocol REN-007: A Population Pharmacokinetic (popPK) Evaluation of RBT-1 - Mayo Clinic

    Known hypersensitivity or previous anaphylaxis to SnPP or FeS. 12. Female subject who is pregnant or breastfeeding. 13. Participation in a study involving ...

  10. Publications - Eva M. Carmona Porquera, M.D., Ph.D. - Mayo Clinic

    Beer anaphylaxis. J Allergy Clin Immunol. 1999 May; 103(5 Pt 1):959-60. View PubMed. PST-20225177. Home; Publications. Fuel groundbreaking medical research ...